AKT1 and Insulin resistance: Ceramide then inhibits the Akt/PKB pathway leading to reduced glucose uptake, lipolysis, gluconeogenesis, and anti-glycogen synthesis, as well as phenotypes of insulin resistance (Figure 2) [30,31].